Navigation Links
Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
Date:4/17/2008

ncludes sutures, implants for orthopedic and spinal surgery, surgical instruments, endoscopes, surgical motor systems, container and storage systems, and vascular therapy products.

Tornier, a Tepha corporate partner since 2007, recently supported the clinical evaluation of the TephaFLEX(R) Absorbable Suture by several leading orthopedic surgeons in the United States. The TephaFLEX(R) Absorbable Suture, FDA 510(k) cleared in February 2007, was utilized in a range of orthopedic soft tissue repair procedures. Tornier, based in Edina, Minnesota, is a leader in the extremity orthopedics market and is collaborating with Tepha on several products for orthopedic soft tissue repair.

About Tepha, Inc.

Tepha, Inc, is a developer of medical devices derived from a new class of resorbable polymers that have been engineered utilizing recombinant DNA technology. The unique biologic and mechanical properties of the Tepha PHA polymers has been recognized by an expanding list of corporate partners that now includes Aesculap AG, ENTrigue Surgical, HemCon Medical Technologies, LifeCell Corporation (Nasdaq: LIFC), NMT Medical (Nasdaq: NMTI), and Tornier, Inc. Tepha received its first FDA 510(k) clearance for its TephaFLEX(R) Absorbable Suture in February, 2007 and the Company and its partners have now received five 510(k)'s covering a range of medical devices including sutures, meshes, and films.

For further information about Tepha, please contact Dr. Ajay Ahuja, M.D., Director of Business Development, Tepha, Inc., 99 Hayden Ave, Lexington, MA 02421, tel: 781-357-1700. Email: contact@tepha.com. Or visit: http://www.tepha.com


'/>"/>
SOURCE Tepha, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Massachusetts General Hospital (MGH), ... AMGN ) announced today that they have launched ... new therapeutic targets and develop novel therapies for ... affects millions worldwide. The MGH-Broad-Amgen collaboration brings together ... human genetics, genomic technology, and drug discovery to ...
(Date:1/15/2014)... , January 15, 2014 ... Ltd., the exclusive worldwide distributor of highly sophisticated agro-breeding ... on January 7, 2014, the Company,s board of directors ... Weiner as its new member of the board. ... executive positions with Teva Pharmaceutical Industries Ltd (NYSE: ...
(Date:1/15/2014)... 15, 2014 Tegra Medical is very pleased ... King as its new Chief Executive Officer.  Mark ... Officer, in which he has overseen the company,s four ... Mississippi , and Costa Rica.  Mr. King joined ... operations, sales, engineering and manufacturing experience in medical device ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... 9, 2011 STAAR Surgical Company (Nasdaq: ... minimally invasive ophthalmic products, today announced that it has ... for the exclusive distribution of STAAR intraocular lenses in ... is publicly traded in Australia, will market STAAR,s Visian ...
... Services, Inc. (Nasdaq: GTIV ) announced today that ... Conference in Miami, Florida at 3:15 p.m. ET on Tuesday, ... Bond and Syndicated Loan Conference in Orlando, Florida at 2:05 ... presentations will be available to the public via live audio ...
Cached Medicine Technology:STAAR Surgical Enters Into Distribution Agreement With Ellex in Australia 2STAAR Surgical Enters Into Distribution Agreement With Ellex in Australia 3Gentiva® Health Services to Present at Upcoming Investor Conferences 2Gentiva® Health Services to Present at Upcoming Investor Conferences 3
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... health care professionals enjoy a pay raise for a job ... care performance may actually backfire. A ... medical groups across California improved significantly following the launch of ... incentives focused on doctors, productivity. Reporting ...
... reined in their hypertension, study found, , MONDAY, ... is better controlled by doctor-pharmacist teams working hand-in-hand ... new study shows. , "When physicians work with ... more effectively," said Barry L. Carter, a professor ...
... , CENTER CITY, Minn., Nov. 23 ... announced the leadership team for its new recovery center ... scheduled to open in late March 2010, and will ... full array of family and outpatient services. , ...
... , DALLAS, Nov. 23 , WHAT: ... arm of The Beryl Companies, the nation,s leading ... how to effectively reach consumers in every generation with a ... of MinuteClinic, this Webinar will supplement Howe,s June 2009 white ...
... , CHERRY HILL, N.J., Nov. 23 In a ... Chief Financial Officers, 72 percent do not believe a new health ... , According to results of the latest survey conducted by the ... topped the list at 85 percent as the biggest national issue. ...
... Minn. -- Major medical errors self-reported by American surgeons are ... today in the online edition of Annals of Surgery ... and the American College of Surgeons. In the ... they made a major error in the three months prior ...
Cached Medicine News:Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 3Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 2Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 3Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2Health News:Tips to Improve Healthcare Customer Service Across All Generations 2Health News:Area Execs Do Not See a Health Care Bill Providing Better Care 2Health News:Burnout and mental distress strongly related to errors by US surgeons 2
Tennant angled tying forceps with extra delicate smooth jaws, 6 mm tying platform, For 9-0 to 11-0 sutures. Overall length 108 mm....
Catalano curved tying forcep has 6 mm V-grove tying platform. Overall length 100 mm....
Kelman - McPherson angled tying forceps is long with tying platform 10 mm, serrated handle and polished finish....
Suture tying forceps (S&T) is straight, 13.5 cm long, flat handle, 9 mm wide, tip diameter 0.3 mm with tying platform....
Medicine Products: